Is Moderna’s vaccine breakthrough really worth $100bn?
The company’s hugely successful Covid shot sent the stock sky-high, but its hefty valuation comes with some big risks
06 July 2021 - 20:19
Just 18 months ago, Moderna was an early-stage biotechnology company working on a new way of making vaccines worth $6.5bn (R92.5bn). Today, after it developed and delivered one of the fastest-arriving and most effective shots against Covid-19, Moderna’s market value is approaching $100bn (R1.423-trillion)...
Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.
This article is free to read if you sign up or sign in.
If you have already registered or subscribed, please sign in to continue.
Questions or problems? Email helpdesk@timeslive.co.za or call 0860 52 52 00.